ALSEVALIMAB
UNII U8LYN0Y118

Substance Identification & Data

This profile provides standardized clinical and technical data for Alsevalimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U8LYN0Y118.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2254029-91-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

U8LYN0Y118

CAS Registry Number

2254029-91-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ALSEVALIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C155967

National Cancer Institute reference terminology for clinical and research data.

INN ID

11301

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Alsevalimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ALSEVALIMAB

Common Names & Synonyms

ALSEVALIMAB [INN]

Systematic Nomenclature

IMMUNOGLOBULIN G1 (DE-450-LYSINE), ANTI-(HUMAN B7 HOMOLOG 4 PROTEIN) (HUMAN MONOCLONAL FPA150 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL FPA150 .KAPPA.CHAIN, DIMER

SYS